Zobrazeno 1 - 10
of 36
pro vyhledávání: '"R. J. Belt"'
Autor:
David C. Caldwell, Thomas J. Lynch, Marsha Jones, Jennifer S. Temel, Tatjana Kolevska, Michael S. Rabin, Lecia V. Sequist, Panos Fidias, Mark S. Huberman, Craig W. Englund, Gail L. Brown, James G. Keck, Martin J. Edelman, Lisa Meng, Ralph V. Boccia, Ostap Melnyk, Howard A. Burris, R. J. Belt, Glenn Mills
Publikováno v:
Journal of Thoracic Oncology. 4:1389-1396
Introduction We aimed to evaluate the safety and efficacy of canfosfamide in combination with carboplatin and paclitaxel as first-line therapy in patients with locally advanced or metastatic non-small cell lung cancer. Methods This was a phase 1-2a,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::194af7d39cde2522b5595453bca5114c
https://doi.org/10.1097/jto.0b013e3181b6b84b
https://doi.org/10.1097/jto.0b013e3181b6b84b
Publikováno v:
Annals of Oncology. 20:850-856
Background: Previous studies of the gemcitabine-pemetrexed combination in patients with late-stage non-small-cell lung cancer (NSCLC) utilized a 90-min delay between gemcitabine and pemetrexed administration. This phase II study evaluated activity wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea32545953b91e4b04ce2a1c0a1a3e4d
https://doi.org/10.1093/annonc/mdn715
https://doi.org/10.1093/annonc/mdn715
Autor:
Rita Axelrod, Francisco Robert, Ronald B. Natale, Steven A. Limentani, Hans Joachim Reimers, Joan H. Schiller, Shihong Sheng, Frank V. Fossella, Jeffrey Crawford, Luis E. Raez, Maria H.L. Ribeiro, Michael Fanucchi, Panos Fidias, R. J. Belt, Oscar Kashala, David P. Carbone, Ramaswamy Govindan, Karen Kelly, Wallace Akerley
Publikováno v:
Journal of Clinical Oncology. 24:5025-5033
PurposeTo evaluate the efficacy and toxicity of bortezomib ± docetaxel as second-line therapy in patients with relapsed or refractory advanced non–small-cell lung cancer (NSCLC).Patients and MethodsPatients were randomly assigned to bortezomib 1.5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70aa9794a781f455d8cc276b3ccd0300
https://doi.org/10.1200/jco.2006.06.1853
https://doi.org/10.1200/jco.2006.06.1853
Autor:
David M. Loesch, Nicholas J. Robert, Robert N. Raju, Robert M. Sayre, Dennis J. Slamon, Kathy S. Albain, Elizabeth Valentine, Brian Leyland-Jones, Lea Fuchs, Cecelia McCullough, Lina Asmar, R. J. Belt, Melody A. Cobleigh, Des Ilegbodu
Publikováno v:
Journal of Clinical Oncology. 24:2786-2792
Purpose This randomized, multicenter, phase III trial evaluated the efficacy and safety of trastuzumab and paclitaxel with or without carboplatin as first-line therapy for women with HER-2–overexpressing metastatic breast cancer (MBC). Patients and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::562679ac8a643c9f6be52a7b6f490fc0
https://doi.org/10.1200/jco.2005.04.1764
https://doi.org/10.1200/jco.2005.04.1764
Publikováno v:
Kerntechnik. 68:78-84
There is evidence in literature that the insertion of flow obstacles in the coolant flow of a boiler flowing in an annular regime postpones the film dryout emergence on the heated surfaces. Specifically, the obstacle is believed to force the depositi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ee9624ff08a3092cd2bd7c604c67d57
https://doi.org/10.1515/kern-2003-0044
https://doi.org/10.1515/kern-2003-0044
Autor:
J Brown, R. J. Belt, M. Thant, Jeremy K. Hon, Y P Maguire, Gary M. Clark, Richard M. Elledge, P Bartels, D. D. Von Hoff
Publikováno v:
Journal of Clinical Oncology. 13:419-423
PURPOSE To determine if a rapid 3H-uridine uptake assay using breast tumor cells from biopsy specimens could predict clinical response to fluorouracil (5FU) in patients with metastatic breast cancer. PATIENTS AND METHODS A double-blind prospective st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::617a2c044124c8b578a6c3cd20f1bfba
https://doi.org/10.1200/jco.1995.13.2.419
https://doi.org/10.1200/jco.1995.13.2.419
Publikováno v:
Journal of Fluid Mechanics, 709, 2012
In fully developed single-phase turbulent flow in straight pipes, it is known that mean motions can occur in the plane of the pipe cross-section, when the cross-section is non-circular, or when the wall roughness is non-uniform around the circumferen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6da1787c97c1b156b00cb72de59cf9b7
http://resolver.tudelft.nl/uuid:9e217367-b237-47c0-9ebe-9a49ee3a6265
http://resolver.tudelft.nl/uuid:9e217367-b237-47c0-9ebe-9a49ee3a6265
Autor:
R J Belt, J R Borst, R. Pugh, T M Dorr, Sylvan B. Green, R D Carter, Carol J. Fabian, Peter M. Ravdin, W L McGuire, Saul E. Rivkin
Publikováno v:
Journal of Clinical Oncology. 10:1284-1291
PURPOSE Southwest Oncology Group (SWOG) protocol 8228 is a prospective trial designed to investigate the prognostic significance of progesterone receptor (PgR) levels in estrogen receptor (ER)-positive breast cancer patients who were treated with tam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb03ccf89dcd5003d8bb5016ead3eb67
https://doi.org/10.1200/jco.1992.10.8.1284
https://doi.org/10.1200/jco.1992.10.8.1284
Autor:
Andre Goy, Lowell L. Hart, Christopher R. Flowers, Shaker R. Dakhil, Charles Holladay, Martha Glenn, Sven de Vos, Stephanie A. Gregory, Tracy Zhang, Anthony Boral, Mansoor N. Saleh, Dipti Patel-Donnelly, R. J. Belt, Mark Knapp, Peter McLaughlin
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(30)
Purpose To determine overall response rate (ORR), time to progression (TTP), and duration of response (DOR) with twice-weekly/weekly bortezomib plus rituximab, and evaluate safety/tolerability, in patients with relapsed or refractory CD20+ follicular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da219e118ae393e2167eb3b85954e9af
https://pubmed.ncbi.nlm.nih.gov/19770386
https://pubmed.ncbi.nlm.nih.gov/19770386
Autor:
R, Pazdur, J J, Ajani, J L, Abbruzzese, R J, Belt, S R, Dakhil, D, Dubovsky, S, Graham, S, Pilat, R, Winn, B, Levin
Publikováno v:
Cancer. 70(8)
Based on initial encouraging results of the combination of 5-fluorouracil (5-FU) with recombinant alpha-2a-interferon (r alpha-2a-IFN) in the treatment of advanced colorectal carcinomas, a clinical trial was conducted using 5-FU with r alpha-2a-IFN i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::61ba5d2a069cbe1fe51c136bb5584ab8
https://pubmed.ncbi.nlm.nih.gov/1394037
https://pubmed.ncbi.nlm.nih.gov/1394037